CCA
CLOV icon

Column Capital Advisors’s Clover Health Investments CLOV Stock Holding History

Column Capital Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$81 Hold
75
– – ﹤0.01% 789
2023
Q2 		$67 Hold
75
– – ﹤0.01% 805
2023
Q1 		$63 Hold
75
– – ﹤0.01% 822
2022
Q4 		$70 Hold
75
– – ﹤0.01% 828
2022
Q3 		$0 Hold
75
– – ﹤0.01% 720
2022
Q2 		$0 Hold
75
– – ﹤0.01% 719
2022
Q1 		$0 Hold
75
– – ﹤0.01% 730
2021
Q4 		$0 Hold
75
– – ﹤0.01% 790
2021
Q3 		$1K Hold
75
– – ﹤0.01% 663
2021
Q2 		$1K Hold
75
– – ﹤0.01% 660
2021
Q1 		$1K Buy
+75
New +$846 ﹤0.01% 654

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return